ACUTE ATYPICAL ENDOPHTHALMITIS FOLLOWING INTRAVITREAL SUSTAINED-RELEASE DEXAMETHASONE IMPLANT: A CASE SERIES.

Yi Yao Brendan Chin1, Tun Hang Yeo1, Maheshwar Bakthavatsalu1

  • 1Department of Ophthalmology and Visual Sciences, Khoo Teck Puat Hospital, Singapore.

Summary

Acute endophthalmitis after intravitreal dexamethasone implant (Ozurdex) can be atypical. Conservative topical treatment may suffice, but some cases require surgery and removal of the Ozurdex implant.